|
|
|
|
||
|
||
|
|
||
| SEARCH | SUBSCRIBE | ||
|
 |
New Method Aids Evaluation of Alzheimer's DrugsBy ERICA GOODE
NY Times, February 6, 2003 Scientists have developed a technique that allows them to watch the destruction by Alzheimer's disease travel through the brains of living patients ``like a flow of lava,'' as one researcher put it. The technique, described today in The Journal of Neuroscience, may help pharmaceutical companies evaluate the effectiveness of Alzheimer's drugs and aid in the early identification of people who are at highest risk for developing the disease. In the technique, a computer analyses single brain scans taken over time and generates three-dimensional videos. ``People have used imaging before, but the studies have really been like taking Polaroid pictures at the ballet,'' said Dr. Paul Thompson, an assistant professor of neurology at the University of California at Los Angeles and the lead author of the report. “This is really the first study to chart the dynamic spread of Alzheimer's in the brain.” Dr. Thompson's research team collaborated with investigators from the University of Queensland in Australia, Addenbrooke's Hospital in Cambridge, England, and GlaxoSmithKline Pharmaceuticals in conducting the study. The videos were based on the analysis of subtle changes in the MRI scans of 12 patients with Alzheimer's, compared with those of of 14 elderly people without the disease. The videos depict the average loss of brain cells in different brain areas for the Alzheimer's patients. Researchers have long known through autopsy studies that Alzheimer's patients show the progressive death of nerve cells in many areas of the brain. But in the videos, the damage can be seen moving from structures involved with memory to brain areas involved in emotion and in the control of behavior. Other regions of the brain - sensory centers responsible for vision and touch, for example - remained untouched, Dr. Thompson said. The researchers found that the loss of brain tissue progressed at a rate of 4 percent to 5 percent each year in the Alzheimer's patients, while in healthy brains, only about 0.5 percent is lost each year in aging. Dr. Thomas Chase, chief of experimental therapeutics at the National Institute of Neurological Disorders and Stroke and an expert on Alzheimer's treatment, said that the new technique ``adds to our understanding of the time course that unfolds in an Alzheimer's brain and therefore is of general interest.'' The ability to see the disease progressing over time in the whole brain might in the future help scientists separate out different subtypes of Alzheimer's, Dr. Chase said. Dr. Antonio Convit, a research scientist at the Nathan S. Kline Institute for Psychiatric Research, called the video technique ``a very promising technology that elegantly confirms previous imaging reports.'' Supplementary Data (Video Sequences)
This page contains supplementary data for the manuscript entitled:DYNAMICS
OF GRAY MATTER LOSS IN ALZHEIMER'S DISEASE
(Authors: Paul Thompson, Kiralee Hayashi, Greig de Zubicaray, Andrew Janke, Stephen Rose, James Semple, David Herman, Michael Hong, Stephanie Dittmer, David Doddrell, Arthur W. Toga)Copyright
© 2002 Global Action on Aging
|
